PRIME ISP Epsidoe 03

Dr. Matthew Smith on Changing Landscape in the Management of mCSPC and nmCRPC

Role of Darolutamide

Dr. Matthew Smith presents case studies on mCSPC, as well as discusses the results of various clinical trials like ARASENS, PEACE-1, and ARASEC. Additionally, he presents case studies on nmCRPC, talking about results from the ARAMIS trial. Following the lecture, a panel discussion was held with Prof Vineet Talwar, Prof Matthew Smith, Dr Krishna Chaitanya, Dr Anita Ramesh, Dr Akhil Kapoor, and Dr Chandrakanth MV. 

Our speakers

    • Dr. Matthew Smith
      Director of the Genitourinary oncology program, Massachusetts General Hospital Cancer Center, Professor of Medicine - Harvard medical school, Boston.

Related content

Dr. Elena Castro Jul'24 Teaser
mHSPC: Early Intensification Strategies
PP-NUB-IN-0196-1, September 2024
Prostate Cancer Awareness Video Teaser
Dr Poulami Basu: Prostate Cancer: Awareness for Better Ou...
PP-NUB-IN-0102-1, September 2024
ARASENS TL Video _ mHSPC Landscape Teaser
mHSPC Treatment Landscape: The Impact of Darolutamide
PP-PF-ONC-SG-0040-1, September 2024